Fresenius Medical Care AG
Fresenius Medical Care AG & Co. KGaA successfully upsizes and extends the maturity of its credit agreement and also extends the maturity of its accounts receivable facility
Fresenius Medical Care AG & Co. KGaA / Schlagwort(e): Sonstiges Fresenius Medical Care successfully upsizes and extends the maturity of its credit agreement and also extends the maturity of its accounts receivable facility Bad Homburg, Germany – Fresenius Medical Care AG & Co. KGaA (the “company” or “Fresenius Medical Care”; Frankfurt Stock Exchange: FME / New York Stock Exchange: FMS), the world’s largest provider of dialysis products and services, has upsized its syndicated credit facility by 850 million U.S. dollar equivalent to a total amount of approximately 4.4 billion U.S. dollar equivalent, with pricing and other conditions more favorable to the company. The amended credit facility consists of revolving facilities and term loans, both U.S. dollar and euro denominated. The final maturity date was extended by two years to October 30, 2019. The facilities will be used to refinance existing debt, for working capital needs and general corporate purposes. Fresenius Medical Care also successfully extended its $800 million accounts receivable facility with improved terms. The new facility will now mature November 24, 2017.
About Fresenius Medical Care For more information about Fresenius Medical Care, visit the company’s website at www.fmc-ag.com. Disclaimer 27.11.2014 Veröffentlichung einer Corporate News/Finanznachricht, übermittelt durch DGAP – ein Service der EQS Group AG. Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Die DGAP Distributionsservices umfassen gesetzliche Meldepflichten, Corporate News/Finanznachrichten und Pressemitteilungen. Medienarchiv unter http://www.dgap-medientreff.de und http://www.dgap.de |
Sprache: | Deutsch | |
Unternehmen: | Fresenius Medical Care AG & Co. KGaA | |
Else-Kröner-Straße 1 | ||
61352 Bad Homburg | ||
Deutschland | ||
Telefon: | +49 (0) 6172- 609 2525 | |
Fax: | +49 (0) 6172- 609 2301 | |
E-Mail: | ir@fmc-ag.com | |
Internet: | www.fmc-ag.de | |
ISIN: | DE0005785802, DE0005785836, | |
WKN: | 578580, 578583 | |
Indizes: | DAX | |
Börsen: | Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart; Terminbörse EUREX; NYSE | |
Ende der Mitteilung | DGAP News-Service |
300001 27.11.2014 |